Gefitinib and diffuse alveolar damage Patient Reports February 12, 2012
Gefitinib Side Effects Report #4591428-8
Gefitinib side effect was reported by a Physician from on Feb 04, 2005. Male patient, 58 years of age, weighting 215.0 lb, was diagnosed with non-small cell lung cancer and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: diffuse alveolar damage, dyspnoea, hypoxia, lower respiratory tract infection, pleuritic pain, pneumonia
, productive cough, respiratory failure. Gefitinib dosage: 250 MG QD PO. During the same period patient was treated with OMEPRAZOLE, PREDNISOLONE, FLUOXETINE, DIFFLAM, GABAPENTIN, ADCAL, FLUTICASONE PROPIONATE. Patient was hospitalized. Patient died on 12/28/2004.Gefitinib Side Effects Report #4617669-9
Gefitinib side effect was reported by a Physician from on Mar 07, 2005. Male patient, 58 years of age, weighting 215.0 lb, was diagnosed with non-small cell lung cancer and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: chest x-ray abnormal, diffuse alveolar damage, hypoxia, lower respiratory tract infection, pneumonia
, respiratory failure, tachycardia. Gefitinib dosage: 250 MG QD PO. During the same period patient was treated with OMEPRAZOLE, PREDNISOLONE, FLUOXETINE, DIFFLAM, GABAPENTIN, ADCAL, FLUTICASONE PROPIONATE. Patient was hospitalized. Patient died on 12/28/2004.Gefitinib Side Effects Report #4629477-3
Gefitinib side effect was reported by a Physician from on Mar 21, 2005. Male patient, 58 years of age, weighting 215.0 lb, was diagnosed with non-small cell lung cancer and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: chest pain
, diffuse alveolar damage, lower respiratory tract infection, lung consolidation, pleuritic pain, pneumonia
, productive cough, respiratory failure. Gefitinib dosage: 250 MG QD PO. During the same period patient was treated with OMEPRAZOLE, PREDNISOLONE, FLUOXETINE, DIFFLAM, GABAPENTIN, ADCAL, FLUTICASONE PROPIONATE. Patient was hospitalized. Patient died on 12/28/2004.
Gefitinib and diffuse alveolar damage 